Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 4,225,512
- Share change
- +2,533,717
- Total reported value
- $32,853,000
- Price per share
- $7.76
- Number of holders
- 23
- Value change
- +$19,634,402
- Number of buys
- 17
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
1.4%
|
834,811
|
$8,665,000 | — | 31 Mar 2015 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.6%
|
357,000
|
$3,634,000 | — | 31 Mar 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$1,446,000 | — | 31 Mar 2015 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$1,382,000 | — | 31 Mar 2015 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.19%
|
115,000
|
$1,194,000 | — | 31 Mar 2015 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
35,000
|
$356,000 | — | 31 Mar 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
22,558
|
$234,000 | — | 31 Mar 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0.04%
|
22,700
|
$230,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
13,841
|
$141,000 | — | 31 Mar 2015 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.01%
|
8,333
|
$85,000 | — | 31 Mar 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,530
|
$25,000 | — | 31 Mar 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,244
|
$13,000 | — | 31 Mar 2015 | |
| Ironwood Financial, llc |
13F
|
Company |
0%
|
500
|
$5,000 | — | 31 Mar 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
269
|
$3,000 | — | 31 Mar 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
209
|
$2,000 | — | 31 Mar 2015 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q2 2015
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.